Free Trial

23,039 Shares in Cognex Co. (NASDAQ:CGNX) Bought by Teza Capital Management LLC

Cognex logo with Computer and Technology background

Teza Capital Management LLC acquired a new position in shares of Cognex Co. (NASDAQ:CGNX - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 23,039 shares of the scientific and technical instruments company's stock, valued at approximately $826,000.

A number of other hedge funds have also recently made changes to their positions in CGNX. Charles Schwab Investment Management Inc. raised its stake in Cognex by 3.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,427,756 shares of the scientific and technical instruments company's stock valued at $51,199,000 after buying an additional 42,292 shares during the last quarter. Smartleaf Asset Management LLC raised its stake in Cognex by 75.1% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,870 shares of the scientific and technical instruments company's stock valued at $102,000 after buying an additional 1,231 shares during the last quarter. Swiss National Bank raised its stake in Cognex by 0.7% in the fourth quarter. Swiss National Bank now owns 337,300 shares of the scientific and technical instruments company's stock valued at $12,096,000 after buying an additional 2,200 shares during the last quarter. Merit Financial Group LLC purchased a new stake in Cognex in the fourth quarter valued at about $267,000. Finally, Proficio Capital Partners LLC purchased a new stake in Cognex in the fourth quarter valued at about $1,215,000. 88.12% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CGNX has been the subject of several research analyst reports. DA Davidson reduced their price objective on Cognex from $35.00 to $32.00 and set a "neutral" rating for the company in a research note on Monday, May 5th. Needham & Company LLC reduced their price objective on Cognex from $41.00 to $33.00 and set a "buy" rating for the company in a research note on Thursday, May 1st. Robert W. Baird reduced their price objective on Cognex from $42.00 to $38.00 and set a "neutral" rating for the company in a research note on Tuesday, February 18th. Cowen upgraded Cognex from a "hold" rating to a "buy" rating in a research note on Monday, April 28th. Finally, Citigroup reduced their price objective on Cognex from $37.00 to $26.00 and set a "neutral" rating for the company in a research note on Monday, April 14th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $39.17.

Read Our Latest Stock Report on Cognex

Insider Buying and Selling at Cognex

In other news, EVP Carl Gerst sold 6,803 shares of the firm's stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $32.73, for a total value of $222,662.19. Following the transaction, the executive vice president now owns 4,566 shares in the company, valued at $149,445.18. This trade represents a 59.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.60% of the stock is owned by corporate insiders.

Cognex Trading Down 1.9%

Shares of CGNX opened at $30.99 on Tuesday. Cognex Co. has a 12 month low of $22.67 and a 12 month high of $53.13. The stock's 50 day moving average is $28.01 and its two-hundred day moving average is $34.18. The firm has a market cap of $5.20 billion, a P/E ratio of 50.80 and a beta of 1.45.

Cognex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th will be issued a $0.08 dividend. This represents a $0.32 annualized dividend and a yield of 1.03%. The ex-dividend date of this dividend is Thursday, May 15th. Cognex's payout ratio is currently 47.06%.

Cognex Profile

(Free Report)

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Read More

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cognex Right Now?

Before you consider Cognex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.

While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines